| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QCO.0B013E3283422CDF |
| P698 | PubMed publication ID | 21150592 |
| P50 | author | Jose R. Arribas | Q37838345 |
| Ignacio Pérez Valero | Q56868275 | ||
| P2093 | author name string | Ignacio Pérez-Valero | |
| P433 | issue | 1 | |
| P304 | page(s) | 7-11 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Protease inhibitor monotherapy | |
| P478 | volume | 24 |
| Q35812907 | A quantitative basis for antiretroviral therapy for HIV-1 infection |
| Q43467476 | A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. |
| Q36374300 | Antiretroviral dynamics determines HIV evolution and predicts therapy outcome |
| Q33572705 | Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201). |
| Q42233102 | Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients |
| Q33725024 | Dolutegravir: clinical efficacy and role in HIV therapy |
| Q28548288 | Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial |
| Q38419599 | HIV in Africa: Challenges and Directions for the Next Decade |
| Q52591808 | High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. |
| Q36311894 | High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting |
| Q35866370 | Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure |
| Q35237575 | Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance. |
| Q87370655 | Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy |
| Q37987855 | Protease inhibitor monotherapy: what is its role? |
| Q37425205 | Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells |
| Q38936786 | Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications |
Search more.